Kelowna, Canada Clinical Trials

A listing of Kelowna, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 25 clinical trials
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (300/L). Eligible patients must have a history of 2 moderate and/or severe COPD exacerbations in the previous year …

antibiotics
eosinophil count
severe chronic obstructive pulmonary disease
bronchodilator
corticosteroids
Research Site
 (180.3 away) Contact site
  • 838 views
  • 10 Sep, 2021
  • +438 other locations
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

The study will evaluate the efficacy and safety of trastuzumab deruxtecan (also known as T-DXd, DS-8201a), either alone or in combination with pertuzumab, in treating patients with Human epidermal growth factor receptor 2 (HER2)-positive breast cancer as a first line of treatment.

Research Site
 (1.0 away) Contact site
  • 2 views
  • 11 Sep, 2021
  • +224 other locations
A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)

This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study …

areata alopecia
Care Clinic Ltd.
 (294.9 away) Contact site
  • 3 views
  • 15 Sep, 2021
  • +59 other locations
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

DESTINY-Breast 08 will investigate the safety, tolerability, PK and preliminary anti-tumour activity of T-DXd in combination with other therapies in patients with Metastatic HER2-low Advanced or Metastatic Breast Cancer

Research Site
 (1.0 away) Contact site
  • 0 views
  • 15 Sep, 2021
  • +27 other locations
Study of TSR-042 an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody in Participants With Advanced Solid Tumors

This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (also known as TSR-042) n participants with advanced solid tumors who have limited available treatment options. The study will be conducted in 2 parts with Part 1 consisting of safety evaluation, pharmacokinetics …

erlotinib
lymphoma
treatment regimen
bilateral oophorectomy
fluoropyrimidine
GSK Investigational Site
 (1.0 away) Contact site
  • 0 views
  • 03 Sep, 2021
  • +187 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

stroke
diabetes
myocardial infarction
arterial disease
stemi
1240101 - Kelowna General Hospital
 (1.0 away) Contact site
  • 1131 views
  • 15 Sep, 2021
  • +3432 other locations
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

HER2
sentinel lymph node biopsy
mastectomy
invasive carcinoma
erbb2
BCCA-Cancer Centre for the Southern Interior
 (1.0 away) Contact site
  • 598 views
  • 15 Sep, 2021
  • +318 other locations
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

The purpose of this research study is to determine if 5 (five) fractions of external radiotherapy with higher radiation doses per fraction to the pelvis leads to similar results to the standard of care external radiotherapy treatment that is comprised of 25 fractions of external radiotherapy with lower radiation doses …

adenocarcinoma
brachytherapy
adenocarcinoma of prostate
Tom Baker Cancer Centre
 (248.4 away) Contact site
  • 6 views
  • 06 Sep, 2021
  • +2 other locations
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Stereotactic Ablative Radiotherapy (SABR) is a modern RT technique that delivers high doses of radiation to small tumor targets using highly conformal techniques. SABR is non-invasive and delivered on an outpatient basis. The purpose of this study is to compare the effect of SABR, relative to standard of care (SOC) …

cancer
metastasis
bone scan
positron emission tomography
stereotactic body radiation therapy
BC Cancer
 (1.0 away) Contact site
  • 31 views
  • 15 Sep, 2021
  • +9 other locations
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

The purpose of this study is to find out whether a new drug, Ipatasertib, can slow the growth of advanced breast cancer when added to standard therapy (Fulvestrant).

advanced breast cancer
erbb2
metastasis
aromatase inhibitor
fulvestrant
BCCA - Cancer Centre for the Southern Interior
 (1.0 away) Contact site
  • 14 views
  • 15 Sep, 2021
  • +13 other locations